| Translated title of the contribution | Cost effectiveness analysis of combined dabrafenib and trametinib in metastatic cutaneous melanoma patients with BRAF V600 mutations |
|---|---|
| Original language | Chinese (Traditional) |
| Supervisors/Advisors |
|
| State | Published - 2021 |
| Externally published | Yes |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver